Kenney Richard T has filed 14 insider transactions across 1 company since December 2023.
Most recent transaction: a option exercise of 200 shares of Sonnet BioTherapeutics Holdings, Inc. ($SONN) on December 02, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 2, 2025 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Kenney Richard T | Chief Medical Officer | M | Series 5 Preferred Stock | 200 | $0.00 | 0.0000 | 7,077,352 | 100.00% | 0.00% |
| Dec. 2, 2025 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Kenney Richard T | Chief Medical Officer | D | Common Stock | 69614 | $0.00 | 0.0000 | 7,077,352 | 100.00% | 0.98% |
| Dec. 2, 2025 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Kenney Richard T | Chief Medical Officer | M | Common Stock | 163760 | $0.00 | 163,760.0000 | 7,077,352 | 9999.99% | 2.31% |
| Dec. 2, 2025 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Kenney Richard T | Chief Medical Officer | D | Common Stock | 163760 | $0.00 | 0.0000 | 7,077,352 | 100.00% | 2.31% |
| Dec. 2, 2025 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Kenney Richard T | Chief Medical Officer | M | Warrant (Common Stock) | 86505 | $0.00 | 0.0000 | 7,077,352 | 100.00% | 1.22% |
| Dec. 2, 2025 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Kenney Richard T | Chief Medical Officer | D | Warrant (Common Stock) | 320000 | $0.00 | 0.0000 | 7,077,352 | 100.00% | 4.52% |
| Dec. 2, 2025 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Kenney Richard T | Chief Medical Officer | D | Common Stock | 9374 | $0.00 | 0.0000 | 7,077,352 | 100.00% | 0.13% |
| Dec. 2, 2025 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Kenney Richard T | Chief Medical Officer | M | Common Stock | 86505 | $0.00 | 86,505.0000 | 7,077,352 | 9999.99% | 1.22% |
| Dec. 2, 2025 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Kenney Richard T | Chief Medical Officer | F | Common Stock | 16891 | $0.00 | 69,614.0000 | 7,077,352 | 19.53% | 0.24% |
| July 14, 2025 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Kenney Richard T | Chief Medical Officer | A | Warrant | 320000 | $0.00 | 320,000.0000 | 3,332,728 | 9999.99% | 9.60% |
| July 14, 2025 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Kenney Richard T | Chief Medical Officer | A | Series 5 Preferred Stock | 200 | $0.00 | 200.0000 | 3,332,728 | 9999.99% | 0.01% |
| June 30, 2025 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Kenney Richard T | Chief Medical Officer | A | Warrant | 86505 | $0.00 | 86,505.0000 | 650,284 | 9999.99% | 13.30% |
| July 11, 2025 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Kenney Richard T | Chief Medical Officer | A | Common Stock | 8000 | $0.00 | 9,374.0000 | 3,332,728 | 582.24% | 0.24% |
| Dec. 11, 2023 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Kenney Richard T | Chief Medical Officer | A | Common Stock | 1271 | $0.00 | 1,374.0000 | 0 | 1233.98% | 0.00% |